GHTF (Global Harmonization Task Force)
GHTF (Global Harmonization Task Force)
PRESENTED BY SUBMITTED TO
YUKENDHIRAN C.V (P1824009) Dr. SABA MAANVIZHI
M. PHARM (REGULATORY AFFAIRS) 1ST DEPT. OF PHARMACEUTICS
YEAR SRFOP, SRIHER
DATE: 06/12/2024
DAY: FRIDAY
CONTENTS
• INTRODUCTION
• TRANSITION TO IMDRF:
• IVD MEDICAL DEVICE:
• CLASSIFICATION OF MEDICAL DEVICES
• OPERATING STRUCTURE
• GHTF STUDY GROUP
• STUDY GROUP 4 DOCUMENTS:
• GENERAL PRINCIPLES
• TRAINING REQUIREMENTS FOR AUDITORS
• OVERVIEW OF TYPICAL AUDIT PROCESS
• AUDITING SUBSYSTEMS
2
INTRODUCTION
1
The Global Harmonization Task Force (GHTF) was an international
initiative founded in 1992 to promote uniformity in medical device
regulations worldwide.
2
It emerged from the collective recognition by governments and the
medical device industry that divergent regulatory requirements were
creating barriers to innovation, trade, and patient access to safe and
effective medical devices
3
FOUNDING MEMBERS:
EUROPEAN
UNION
UNITED
STATES
JAPAN
CANADA
4
AUSTRALIA
TRANSITION TO IMDRF:
1 In 2011, GHTF was dissolved, and its 2 IMDRF expanded the scope of GHTF,
work transitioned to the International
incorporating more countries (e.g.,
Medical Device Regulators Forum
Brazil, China, Russia) and addressing
(IMDRF).
modern challenges like software as a
medical device (SaMD), AI, and
cybersecurity in medical devices.
5
KEY MILESTONES:
1 • Formation of GHTF to address global differences in medical device regulations and
9 create common guidelines.
9
2
1 • Development of the GHTF structure, divided into five Study Groups focused on
9 regulatory requirements, quality systems, vigilance, clinical safety, and standards.
9
4
1 • Published foundational guidance documents, including the definition of medical
9 devices, risk classification, and post-market surveillance.
9
9
2 • Worked toward wider global adoption of harmonized standards and built regulatory
0 frameworks for emerging markets.
0
6
2 • GHTF was dissolved, and its mission continued through the International Medical
Device Regulators Forum (IMDRF), with a focus on deeper regulatory
0 convergence and global collaboration.
1
1 6
IVD MEDICAL DEVICE:
7
FACTORS INFLUENCING IVD MEDICAL DEVICE CLASSIFICATION
8
CLASSIFICATION OF MEDICAL DEVICES
9
OPERATING STRUCTURE
STEERING COMMITTEE:
10
ROLE OF STEERING COMMITTEE:
11
GHTF STUDY GROUP
12
STUDY GROUPS
Manufacture
Packaging and
Labelling
Group 3 & 4
(Quality
Advertising
System/Audi
t) Sale
Group 1
Group 2 (Technical
Use
(Postmarke dossier)
t
Disposal
Surveillanc
e)
14
STUDY GROUP 4 - AUDITING
STUDY GROUP 4 is concerned with examining current quality systems auditing
practices and the harmonization of the auditing process.
ROLE OF GHTF STUDY GROUP 4:
Has been charged with the task of examining quality management system auditing practices
and developing guidance documents providing harmonized principles for the medical
device auditing process.
Provide guidance for parties responsible for establishing, planning, carrying out and
documenting audits of quality management systems to address regulatory requirements for
manufacturers of medical devices.
Outline competence criteria for the auditing team.
Eliminate duplication of effort and inconsistencies in auditing practices Study Group 4
Began work on the series of documents in 1994-1996. 15
GHTF STUDY GROUP 4 (SG4) ADTOPED COUNTRIES
GHTF Study Group 4 (SG4) documents on auditing practices have been widely adopted or
referenced by many countries, particularly those aligning with international medical device
standards. Key countries and regions include:
Founding Members: Other Adopters:
•United States •China
•European Union •South Korea
•Japan •Brazil
•Canada •Russia
•Australia •Taiwan
•Singapore
•India
16
STUDY GROUP 4 DOCUMENTS:
INTRODUCTION:
This document provides guidance for regulators and auditing organizations on auditing
medical device manufacturers' quality management systems using a process-based approach
(e.g., ISO 13485:2003, 21 CFR Part 820). It supports global harmonization of regulatory
systems and ensures safe, effective devices through independent, objective compliance
evaluations. Audits may serve as part of the broader conformity assessment required by
regulations.
Potential benefits for the patients/users, regulators, auditing organizations or auditees include:
• A high degree of assurance (along with technical evaluation, where required in addition) that
safe and effective devices will be available
• Independent, reliable, objective evaluation of compliance with regulatory requirements of
the manufacturer's quality management system 17
ARCHIVED DOCUMENT
21
Purpose
22
GENERAL PRINCIPLES
Key Sections
1.Auditing Organization Requirements:
1. Must be impartial, competent, legally responsible, and capable of safeguarding
confidentiality.
2. Should document its organizational structure, implement a QMS, and ensure consistency in
audits.
2.Audit Team Competence:
1. Teams must have relevant knowledge of medical devices, regulatory standards, and quality
systems.
2. Auditors should have specific qualifications, training, and experience in areas like device
technology and regulatory frameworks.
23
GENERAL PRINCIPLES
3. Audit Types:
•Full Audit: Comprehensive review, typically for initial
certifications.
•Partial Audit: Focused on specific subsystems or
processes.
•Surveillance Audit: Periodic checks to ensure ongoing
compliance.
•Special Audits: Triggered by significant changes or
identified risks.
•Combined/Joint Audits: Cover multiple regulatory
requirements or involve multiple organizations.
24
GENERAL PRINCIPLES
4. Audit Process:
Preparation: Define scope, objectives, and criteria; appoint team; review QMS documentation.
recommendations.
5. Audit Documentation:
Must include plans, records, findings, and reports sufficient to demonstrate compliance,
1. Core Knowledge
•Auditors must understand the principles and
applications of quality management systems and
auditing, focusing on their relevance to medical
device manufacturers.
•They should be trained in effective auditing
techniques, including interviewing skills, collecting
and documenting evidence, and reporting findings
such as non-conformities.
•Familiarity with the policies, procedures, and
operational framework of the auditing organization is
26
essential.
TRAINING REQUIREMENTS FOR AUDITORS
2. Regulatory Knowledge
•A deep understanding of the legal frameworks governing medical devices, including
compliance requirements and the role of auditing organizations.
•Knowledge of the essential principles of medical device safety, intended use, associated risks,
and key design and manufacturing processes.
•Specialized training may be required for high-risk or technical areas like sterilization methods,
in-vitro diagnostics, and tissue processing technologies.
3. Practical (On-the-Job) Training
•Trainees gain hands-on experience by observing audits conducted by experienced auditors,
progressively transitioning to active participation.
•They conduct supervised audits where mentors provide evaluations and constructive feedback.
•Continuous guidance from a mentor fosters expertise and helps refine auditing skills over time . 27
Overview of Typical Audit Process
Conduct on-site audit
Initiate the audit activities
- define audit objectives, scope
and criteria - conduct opening meeting
- establish initial contact with - communication during the
the manufacturer and/or audit
auditee - roles and responsibilities of
- appoint the lead auditor guides and observers
- determine the feasibility of - collect and verifying
the audit information
29
Auditing Subsystems
1. Management:
GOAL: The purpose of the management subsystem audit is to evaluate whether top
management ensures that an adequate and effective quality management system has been
established and maintained.
2. Corrective and Preventive Actions – CAPA
GOAL: The purpose of auditing the CAPA subsystem (including reporting/tracking) is to
confirm that information is collected and analyzed to identify actual and potential product
and quality problems, that these are investigated, and appropriate and effective corrective and
preventive actions are taken.
30
Auditing Subsystems
32
REFERENCES:
Websites:
• https://www.imdrf.org/
Website PDF
• https://www.imdrf.org/sites/default/files/docs/ghtf/final/sg4/technical-docs/ghtf-sg4-
n30r16-2005-regulatory-auditing-device-manufacturer-050915.pdf
• https://www.imdrf.org/sites/default/files/docs/ghtf/archived/sg4/technical-docs/ghtf-
sg4-guidelines-auditing-qms-part-1-general-requirements-080827.pdf
• https://web.archive.org/web/20061006202911/http://www.ghtf.org/sg4/inventorysg
4/trainingfinal.pdf
33
THANK
YOU
34